Healthcare Cold Chain Logistics Market Overview
The global healthcare cold chain logistics market is estimated to grow from USD 197.7 billion in 2024 to reach USD 207.0 billion in 2025 and USD 320.9 billion by 2035, representing a higher CAGR of 4.5% during the forecast period.
The origins of the cold chain for transportation of temperature sensitive products can be traced back to 1797, when British fishermen first used natural ice to preserve their fish stock. Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures for transport. In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain dependent.
The growing complexity of biologics, increase in the development of antibody based therapeutics and cell & gene therapies, will drive the demand for healthcare cold chain logistics.
Healthcare Cold Chain Logistics Market: Key Insights
The ‘Healthcare Cold Chain Logistics Market, till 2035’ report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunities of the healthcare cold chain logistics market.The key analysis from the market report are mentioned below.
In addition, the industry has witnessed several facility / capability expansions and acquisitions owing to an increasing demand for cold chain logistics services, which is indicative of the growing interest of stakeholders in this particular type of supply chain. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.
Need for Healthcare Cold Chain
In addition to the growing pipeline of biologics and vaccines, other healthcare products are also required to be shipped / stored under specific temperature conditions include aerosols, blood plasma samples, certain types of diagnostics kits, fertility samples, and laboratory specimens. For some products, even the slightest variations in temperature / storage conditions can adversely alter their integrity and / or viability.
Market Drivers: Rising Demand for Biologics and Vaccines
The COVID-19 pandemic has increased the number of development programs for vaccines, significantly raising the demand for cold chain service providers in the foreseen future. In order to cope with increased inflow of patients, countries must prepare sustainable cold chain logistics to deliver / supply COVID-19 vaccine to different parts of globe.
Over the years, the growing demand for such products has necessitated the need for well-defined infrastructure and protocols to support cold chain dependent logistics operations. Further, stakeholders in this segment of the industry have designed and established a variety of innovative solutions to serve the evolving demands of the healthcare sector.
Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business strategies and operational models to cope up with the future needs.
Healthcare Cold Chain Logistics Market Trends
Connected cold chain solutions have been observed to offer a variety of advantages over conventional methodologies, such as automation of most of the steps and elimination of human handling errors that are associated with human intervention.
In addition, the industry has witnessed several facility / capability expansions and acquisitions owing to an increasing demand for cold chain logistics services, which is indicative of the growing interest of stakeholders in this particular type of supply chain.
Scope of Healthcare Cold Chain Logistics Market Report
The key objective of healthcare cold chain logistics market report is to provide a detailed market analysis in order to estimate the existing market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics and future opportunity during the forecast period.
Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the forecast period, till 2035. In addition, we have provided the likely distribution of the future opportunity based on [A] regional evolution of the market covering key geographies, such as North America (the US, Canada and Mexico), Europe (the UK, Germany, France, Germany, Spain and Italy), Asia-Pacific and Rest of the World (Australia, China, India, and Japan), [B] type of products (cell therapies, vaccines, and human organs), [C] holding temperature ranges (refrigerated, frozen, and cryogenic), [D] type of containers (active and passive containers), and [E] type of end-users (industry players and non-industry players).
In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.
The opinions and insights presented in this market research report were also influenced by discussions conducted with several stakeholders in healthcare cold chain logistics market. The market report features detailed transcripts of interviews held with the following individuals:
- Marketing Communications Manager, Large Company, Russia
- Chief Clinical Officer, Mid-Sized Pharmaceutical Company, UK
- Health Specialist, Non-Profit Organization, US
- Supply Chain Manager, Large-Size Pharmaceutical COmpany, Saudi Arabia
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.
Key Companies in Healthcare Cold Chain Logistics Market
Examples of key pharmaceutical cold chain logistics companies engaged in healthcare cold chain logistics market (which have also been profiled in this market report; the complete list of pharmaceutical cold chain logistics companies is available in the full report) include Cryoport, Lynden International Logistics, PAREXEL, DHL Express, United Parcel Service, GAC and Yusen Logistics. This market report includes an easily searchable excel database of all the pharma cold chain logistics companies providing cold chain logistics services to the healthcare industry, worldwide.
Healthcare Cold Chain Logistics Market Report Coverage
Amongst other elements, the market research report features:
- An analysis comparing the logistical complexities associated with cell therapies, vaccines and human organs, based on several parameters, such as holding temperatures, delivery time restrictions, handling / transportation requirements, and storage related needs.
- A detailed assessment of the overall market landscape, featuring a comprehensive list of over 80 pharma cold chain logistics companies that offer cold chain logistics services for cell therapies, vaccines and human organs, and detailed analyses based on a number of parameters, such as the location of headquarters, size of employee base, type of products (cell therapies, vaccines, human organs, pharmaceutical products, and others), type of services offered (storage, packaging, and transportation), mode of transportation (ground, air, and ocean), holding temperature range (ambient, refrigerated, frozen, and deep frozen / cryogenic), type of packaging methods (dry ice, liquid nitrogen, and gel packs), type of container (active and passive containers), type of end-users (industry players and non-industry players), geographical activity and location of cold chain facilities.
- An insightful 2X2 representation of the results of a competitiveness analysis of various logistics service providers (segregated into three peer groups based on their employee count (small-sized (1-200 employees), mid-sized (>201-1,000 employees) and large (>1,000 employees)), highlighting capable players in healthcare cold chain logistics market, based on their cold chain logistics capabilities (such as type(s) of container, type(s) of service(s) offered, holding temperature range, modes of transportation employed, geographical activity and type(s) of cold chain product(s)) and supplier power.
- Elaborate profiles of leading cold chain logistics service providers (shortlisted on the basis of the company competitiveness analysis), featuring an overview of the company, its financial information (if available), funding information (if available), information on cold chain logistics service(s) / product(s), recent partnerships, and a comprehensive future outlook.
- An analysis of the partnerships that have been established in the recent past, covering service alliances, logistics service agreements, merger / acquisitions, equipment development / manufacturing agreements, R&D agreements, and joint ventures.
- A detailed discussion on the various regulatory guidelines that have been laid down by major regulatory bodies (such as European Medicines Agency (EMA), United States Food and Drug Administration (USFDA), Health Canada (HC), International Air Transport Association (IATA), International Council for Harmonisation (ICH), International Safe Transit Association (ISTA), Parenteral Drug Association (PDA), United States Pharmacopeia (USP), and World Health Organization (WHO)), specific to cold chain management. In addition, it features an insightful analysis, comparing regulatory authorities based on the guidelines issued by them for different stages of the cold chain.
- A case study on the cold chain management strategies used for over 190 drugs (both biologics and small molecules)that were approved in the last five years, highlighting year-wise trend of cold chain adoption. In addition, it analyzes the cold chain temperature requirements of these drugs, based on several parameters, including type of molecule(s), dosage form and route of administration.
- A detailed estimation of the likely demand for logistics services for [A] cell therapies (including stem cell therapies, T-cell therapies, dendritic cell therapies, natural killer cell therapies and tumor therapies), considering the contributions of clinical and commercial stage products over the period, till 2035; [B] vaccines (including over 15 types of mandatory and optional vaccines), considering the contributions of both clinical and commercially available products for both infants and adults, over the period, till 2035; and [C] human organs (including heart, intestine, kidney, liver, lung, and pancreas) for transplants, over the period, till 2035.
- A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry’s evolution, under a comprehensive SWOT framework. It also includes a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall cold chain logistics market.
- A discussion on the upcoming tools / technologies (such as integration of automation and robotics, cloud computing, blockchain technology, artificial intelligence and other such advanced technical solutions) in the field of healthcare cold chain logistics market and their likely impact on the future evolution of this market.
Recent Developments in Healthcare Cold Chain Logistics Market
Several recent developments have taken place in the field of healthcare cold chain logistics. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
- In February 2026, DHL Supply Chain signed an MOU with RLCold in order to develop over 5 million square feet of advanced temperature-controlled facilities across North America. The partnership targets multi-temperature distribution centers for food & beverage but enhances cold chain infrastructure applicable to healthcare logistics needs.
- In November 2025, UPS acquired Andlauer Healthcare Group for USD $1.6 billion in order to enhance cold chain transportation solutions for the healthcare sector.
Frequently Asked Questions
Question 1: What is cold chain logistics?
Answer: Cold chain logistics in pharmaceuticals refers to a supply chain which handles temperature-sensitive and perishable products, including vaccines, biologics and organs.
Question 2: How big is the healthcare cold chain logistics market?
Answer: The healthcare cold chain logistics market size is estimated to be worth USD 207.6 billion in 2025.
Question 3: What is the projected market growth of the healthcare cold chain logistics market?
Answer: The healthcare cold chain logistics market for healthcare is expected to grow at compounded annual growth rate (CAGR) of 4.5% during the forecast period, till 2035.
Question 4: Who are the leading logistics providers in the healthcare cold chain logistics industry?
Answer: Cryoport, Lynden International Logistics, PAREXEL, DHL Express, United Parcel Service, GAC and Yusen Logistics.
Question 5: Which type of human organ is primarily transported?
Answer: Around 65% of the companies engaged in the healthcare cold chain logistics market offer transportation services for kidneys
Question 6: Which type of partnership model is majorly opted by the players engaged in healthcare cold chain logistics industry?
Answer: Majority (36%) of the partnership deals in the healthcare cold chain logistics market were primarily inked for service alliances.
